In vitro and in vivo hepatotoxicity study of Afriplex™ GRT through an inflammatory response
The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with e...
Gespeichert in:
| Veröffentlicht in: | Toxicology reports Jg. 9; S. 1920 - 1928 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Ireland
Elsevier B.V
01.01.2022
Elsevier |
| Schlagworte: | |
| ISSN: | 2214-7500, 2214-7500 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats.
Afriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed.
Afriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis.
The beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway.
[Display omitted]
•Afriplex GRT sub-chronic administration to Sprague Dawley does not impact the liver histology.•High dosage of Afriplex GRT increases the AST levels within acceptable ranges.•Inflammatory genes expression showed no response to high levels of Afriplex GRT™•Toxicity of plant based active medicinal products need to be tested for toxicity.•Sprague Dawley responded to acute carbon tetrachloride with macro vesicular steatosis. |
|---|---|
| AbstractList | Background: The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats. Methods: Afriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed. Results: Afriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis. Conclusion: The beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway. The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats. Afriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed. Afriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis. The beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway. The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats. Afriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed. Afriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis. The beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway. ga1 • Afriplex GRT sub-chronic administration to Sprague Dawley does not impact the liver histology. • High dosage of Afriplex GRT increases the AST levels within acceptable ranges. • Inflammatory genes expression showed no response to high levels of Afriplex GRT™ • Toxicity of plant based active medicinal products need to be tested for toxicity. • Sprague Dawley responded to acute carbon tetrachloride with macro vesicular steatosis. The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats.BackgroundThe focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats.Afriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed.MethodsAfriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed.Afriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis.ResultsAfriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis.The beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway.ConclusionThe beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway. The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed several beneficial effects, this led to the standardized production of a pharmaceutical grade green rooibos extract (Afriplex TM GRT) with enhanced polyphenolic content. The aim of this study was to assess toxicity of Afriplex TM GRT in HepG2/C3A cells and Sprague Dawley rats. Afriplex GRT TM (0.1, 1, 10, 100, or 1000 μg/mL) in DMSO was added to the media to the final 0.01% DMSO for treatment of HepG2/C3A for 1, 24 and 48 hrs followed by MTT and ATP assays. Sprague Dawley rats were grouped to Control, Afriplex TM GRT treated (10, 100 and 300 mg/kg); and acute (24hrs tetrachloromethane (CCl 4) injected hepatotoxicity control). Serum biochemistry, histology and Western blot analysis on liver were performed. Afriplex TM GRT significantly reduced cell viability at 100 and 1000μg/mL after 48 hrs. Acute CCl 4 treatment significantly increased serum alanine aminotransferase in rats. The highest extract treatment of 300 mg/kg significantly elevated aspartate amino transferase. There was severe macro vesicular in the CCl 4 group whereas mild to moderate micro vesicular steatosis was seen in the 300 mg/kg Afriplex TM GRT treated group. Highest extract treatment significantly reduced NFkB expression on Western blot analysis. The beneficial effects of pharmaceutical grade Afriplex GRT TM are concentration and dosage based. Afriplex GRT TM exerts its beneficial effects via NFkB as demonstrated by the dose dependent reduction of NFkB on Western blot analysis. More work need to be done to explore the exact mechanism that occurs in the NFkB pathway. [Display omitted] •Afriplex GRT sub-chronic administration to Sprague Dawley does not impact the liver histology.•High dosage of Afriplex GRT increases the AST levels within acceptable ranges.•Inflammatory genes expression showed no response to high levels of Afriplex GRT™•Toxicity of plant based active medicinal products need to be tested for toxicity.•Sprague Dawley responded to acute carbon tetrachloride with macro vesicular steatosis. |
| Author | Mosa, Rebamang Louw, Johan Mabuda, Thendo I. Kappo, Abidemi Paul Muller, Christo J.F. Gabuza, Kwazikwakhe B. Buthelezi, Ntandoyenkosi |
| Author_xml | – sequence: 1 givenname: Kwazikwakhe B. surname: Gabuza fullname: Gabuza, Kwazikwakhe B. email: Kwazi.gabuza@mrc.ac.za organization: Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa – sequence: 2 givenname: Ntandoyenkosi surname: Buthelezi fullname: Buthelezi, Ntandoyenkosi organization: Department of Biochemistry and Microbiology, University of Zululand, eMpangeni, South Africa – sequence: 3 givenname: Abidemi Paul surname: Kappo fullname: Kappo, Abidemi Paul organization: Department of Biochemistry and Microbiology, University of Zululand, eMpangeni, South Africa – sequence: 4 givenname: Thendo I. surname: Mabuda fullname: Mabuda, Thendo I. organization: Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa – sequence: 5 givenname: Rebamang surname: Mosa fullname: Mosa, Rebamang organization: Department of Biochemistry and Microbiology, University of Zululand, eMpangeni, South Africa – sequence: 6 givenname: Johan surname: Louw fullname: Louw, Johan organization: Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa – sequence: 7 givenname: Christo J.F. surname: Muller fullname: Muller, Christo J.F. organization: Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36518449$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFks1u1DAUhSNUREvpGyDkJZsZHMc_CQukqiplpEpIqCyRdetcz3iUxMF2Rp09T8Kj8SR4mClqWdCV7eNzPl_53pfF0eAHLIrXJZ2XtJTv1vPk7wKOc0YZy9KcUvmsOGGs5DMlKD16sD8uzmJcU0pLJiQV_EVxXElR1pw3J8W3xUA2LgVPYGiJ2x02nqxwhOTzE864tCUxTe2WeEvObXBjh3e_fvwkV19uSFoFPy1XOZujtoO-z7GwJQHj6IeIr4rnFrqIZ4f1tPj68fLm4tPs-vPV4uL8ema4UnIGHLiqy4pxgyZLNSK0KEAwTumttYJLQMZU24IBtKYUbVUZIS0wsGhYdVos9tzWw1qPwfUQttqD038EH5YaQnKmQy2lYA1TNVUMeM2bOmNt1VDbyKoUoDLrw541Trc9tgaHFKB7BH18M7iVXvqNbhRnTdVkwNsDIPjvE8akexcNdh0M6KeoWV1xJmhNxdNWJXgtpGI0W988LOtvPfetzIb3e4MJPsaAVufeQXJ-V6XrdEn1bnT0Wu9HR-9GZ6fm0clh_k_4nv9E7PBXmJu7cRh0NA4Hg60LaFL-ffd_wG_E3eGj |
| CitedBy_id | crossref_primary_10_12944_CRNFSJ_12_3_24 crossref_primary_10_3389_fphar_2023_1328828 crossref_primary_10_1371_journal_pone_0297572 crossref_primary_10_3390_nu15071751 |
| Cites_doi | 10.1021/tx3001708 10.2174/1568026013394831 10.3390/ijms23052764 10.1111/j.1572-0241.1999.01377.x 10.4254/wjh.v9.i16.715 10.1016/j.phrs.2017.11.030 10.1083/jcb.140.6.1485 10.1016/j.nutres.2008.08.002 10.1136/gutjnl-2016-313369 10.3109/03602532.2011.602688 10.1055/s-0029-1240002 10.1007/s00228-009-0776-7 10.1021/jf0344643 10.14309/crj.2013.20 10.1007/s00204-015-1456-2 10.1096/fj.07-9574LSF 10.1016/S0300-483X(98)00095-X 10.1016/j.acthis.2019.05.008 10.1016/B978-0-12-405927-6.00013-8 10.1016/0022-1759(83)90303-4 10.1021/jf960281n 10.1007/s10753-014-0049-1 10.1053/gast.2002.33573 10.3389/fphys.2015.00363 10.1002/ptr.1992 10.3390/molecules21111515 10.1007/s10495-007-0155-8 10.1016/j.canlet.2004.11.014 10.1016/j.phymed.2013.10.029 10.3390/molecules201219868 10.1016/j.phymed.2008.11.009 10.1021/mp060011k 10.1080/07315724.2006.10719518 10.1101/cshperspect.a006080 10.1016/j.livres.2020.10.003 10.1016/j.jep.2003.09.037 10.1016/j.toxlet.2021.05.012 10.3748/wjg.v22.i30.6890 10.1016/j.canlet.2004.07.013 10.1056/NEJMra052270 10.1016/j.mayocp.2013.09.016 10.1021/jf000802d 10.1155/2013/569037 10.1055/s-0034-1375958 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors 2022 The Authors. 2022 The Authors 2022 |
| Copyright_xml | – notice: 2022 The Authors – notice: 2022 The Authors. – notice: 2022 The Authors 2022 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1016/j.toxrep.2022.10.006 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2214-7500 |
| EndPage | 1928 |
| ExternalDocumentID | oai_doaj_org_article_66529278072a4849827df390f96315a7 PMC9742939 36518449 10_1016_j_toxrep_2022_10_006 S2214750022002025 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 0SF 4.4 457 53G 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADBBV ADEZE AEXQZ AFTJW AGHFR AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HYE HZ~ IPNFZ IXB KQ8 M41 M~E NCXOZ O9- OK1 RIG ROL RPM SSZ AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFJKZ AFPUW AIGII AKBMS AKYEP APXCP CITATION NPM 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c4776-a4a4781324cecc478eeade5a52400bff546ae227ddacaefc15d33c56fa2afec23 |
| IEDL.DBID | DOA |
| ISSN | 2214-7500 |
| IngestDate | Fri Oct 03 12:39:56 EDT 2025 Tue Sep 30 17:17:45 EDT 2025 Thu Oct 02 10:23:46 EDT 2025 Fri Jul 11 09:24:55 EDT 2025 Thu Jan 02 22:53:14 EST 2025 Sat Nov 29 06:42:55 EST 2025 Tue Nov 18 22:01:45 EST 2025 Sat Jun 01 15:41:08 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Aspalathin-rich Rooibos Sprague Dawley Hepatotoxicity HepG2/C3A |
| Language | English |
| License | This is an open access article under the CC BY license. 2022 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4776-a4a4781324cecc478eeade5a52400bff546ae227ddacaefc15d33c56fa2afec23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/66529278072a4849827df390f96315a7 |
| PMID | 36518449 |
| PQID | 2754856720 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_66529278072a4849827df390f96315a7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9742939 proquest_miscellaneous_2834250805 proquest_miscellaneous_2754856720 pubmed_primary_36518449 crossref_citationtrail_10_1016_j_toxrep_2022_10_006 crossref_primary_10_1016_j_toxrep_2022_10_006 elsevier_sciencedirect_doi_10_1016_j_toxrep_2022_10_006 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Ireland |
| PublicationPlace_xml | – name: Ireland |
| PublicationTitle | Toxicology reports |
| PublicationTitleAlternate | Toxicol Rep |
| PublicationYear | 2022 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | El-Sayed (bib2) 2016; 0 Clark, Brancati, Diehl (bib6) 2002; 122 Moghaddam, Eggers, Calabrese (bib44) 1998; 130 Marnewick (bib27) 2010 Björnsson (bib5) 2015; 89 Mosmann (bib33) 1983; 65 Brunt, Janney, Bisceglie, Neuschwander-Tetri, Bacon (bib40) 1999; 94 Yao (bib51) 2016; 22 Marnewick (bib56) 2005; 224 Kullak-Ublick (bib10) 2017; 66 Patel (bib32) 2016; 21 Leise, Poterucha, Talwalkar (bib4) 2014; 89 Erlwanger, Ibrahim (bib23) 2017; 5 Mancini (bib53) 1998; 140 Vitamin K.: A vital micronutrient with the cardioprotective potential against diabetes-associated complications | Elsevier Enhanced Reader. Achliya, Wadodkar, Dorle (bib45) 2004; 90 Ahmadi (bib58) 2021; 349 Dorai, Aggarwal (bib54) 2004; 215 Villanueva-Paz (bib13) 2021; 10 Lehucher-Michel (bib14) 2001; 30 Hochhauser (bib48) 2008; 13 . NF-κB in oxidative stress | Elsevier Enhanced Reader. Holder, Goth-Goldstein, Lucas, Koshland (bib43) 2012; 25 Reagan-Shaw, Nihal, Ahmad (bib38) 2007; 22 Lauren Standley, † et al. Influence of Processing Stages on Antimutagenic and Antioxidant Potentials of Rooibos Tea. (2000) doi Navarro, Senior (bib3) 2006; 354 Cabrera, Artacho, Giménez (bib28) 2006; 25 Ghibellini, Leslie, Brouwer (bib8) 2006; 3 Redbook 2000: IV.B.1. General Guidelines for Designing and Conducting Toxicity Studies | FDA. Jaeschke, McGill, Ramachandran (bib12) 2012; 44 Wang, Henning, Heber (bib42) 2010; 5 Engels, Wang, Matoso, Maidan, Wands (bib30) 2013; 1 Marnewick, Joubert, Swart, Van Der Westhuizen, Gelderblom (bib25) 2003; 51 Salvoza, Giraudi, Tiribelli, Rosso (bib18) 2022; 23 Navarro, Lucena (bib20) 2014; 34 Ommati (bib16) 2021; 5 Ku, S.-K.K., Kwak, S., Kim, Y. & Bae, J.-S.S. Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) Inhibits High Glucose-Induced Inflammation In Vitro and In Vivo. Nuran Ercal, Hande Gurer-Orhan (bib11) 2001; 1 Astrid von Gadow,† , Elizabeth Joubert,*,‡ and & Hansmann‡, C.F. Comparison of the Antioxidant Activity of Aspalathin with That of Other Plant Phenols of Rooibos Tea (Aspalathus linearis), α-Tocopherol, BHT, and BHA. (1997) doi:10.1021/JF960281N. Kawano (bib24) 2009; 16 445–455. Singh, Cho, Upadhyay (bib7) 2016; 6 Dludla (bib29) 2014; 21 Layman, Pereira, Chellan, Huisamen, Kotzé (bib39) 2019; 121 World Health Organization (WHO). WHO Global Report on Traditional and Alternate Medicine. (2019). Mechanisms of NF-κB p65 and strategies for therapeutic manipulat | JIR. Al-Yahya (bib46) 2013; 2013 Aguila, Fernandes-Santos, Mulder, Faria, Mandarim-de-Lacerda (bib49) 2009 van der Merwe, de Beer, Joubert, Gelderblom (bib35) 2015; 20 Bell, Chalasani (bib1) 2009; 29 McKay, Blumberg (bib22) 2007; vol. 21 Shahat, Marzouk (bib55) 2013 Benedict, Zhang (bib41) 2017 Hinton, D. M. US FDA "Redbook II" Immunotoxicity Testing Guidelines and Research in Immunotoxicity Evaluations of Food Chemicals and New Food Proteins. Chan (bib9) 2009 Seo, Fischer, Efferth (bib17) 2018; 129 Green, Llambi (bib52) 2015; 7 Sinisalo, Enkovaara, Kivistö (bib31) 2010; vol. 66 Kreuz, Joubert, Waldmann, Ternes (bib50) 2008; 28 Marnewick (10.1016/j.toxrep.2022.10.006_bib27) 2010 Patel (10.1016/j.toxrep.2022.10.006_bib32) 2016; 21 Marnewick (10.1016/j.toxrep.2022.10.006_bib56) 2005; 224 Cabrera (10.1016/j.toxrep.2022.10.006_bib28) 2006; 25 Bell (10.1016/j.toxrep.2022.10.006_bib1) 2009; 29 Jaeschke (10.1016/j.toxrep.2022.10.006_bib12) 2012; 44 Lehucher-Michel (10.1016/j.toxrep.2022.10.006_bib14) 2001; 30 Reagan-Shaw (10.1016/j.toxrep.2022.10.006_bib38) 2007; 22 Benedict (10.1016/j.toxrep.2022.10.006_bib41) 2017 Seo (10.1016/j.toxrep.2022.10.006_bib17) 2018; 129 Marnewick (10.1016/j.toxrep.2022.10.006_bib25) 2003; 51 Kullak-Ublick (10.1016/j.toxrep.2022.10.006_bib10) 2017; 66 Layman (10.1016/j.toxrep.2022.10.006_bib39) 2019; 121 10.1016/j.toxrep.2022.10.006_bib57 10.1016/j.toxrep.2022.10.006_bib15 Salvoza (10.1016/j.toxrep.2022.10.006_bib18) 2022; 23 Kreuz (10.1016/j.toxrep.2022.10.006_bib50) 2008; 28 10.1016/j.toxrep.2022.10.006_bib19 Singh (10.1016/j.toxrep.2022.10.006_bib7) 2016; 6 Navarro (10.1016/j.toxrep.2022.10.006_bib20) 2014; 34 Kawano (10.1016/j.toxrep.2022.10.006_bib24) 2009; 16 McKay (10.1016/j.toxrep.2022.10.006_bib22) 2007; vol. 21 Moghaddam (10.1016/j.toxrep.2022.10.006_bib44) 1998; 130 Ghibellini (10.1016/j.toxrep.2022.10.006_bib8) 2006; 3 van der Merwe (10.1016/j.toxrep.2022.10.006_bib35) 2015; 20 Shahat (10.1016/j.toxrep.2022.10.006_bib55) 2013 Sinisalo (10.1016/j.toxrep.2022.10.006_bib31) 2010; vol. 66 10.1016/j.toxrep.2022.10.006_bib21 Villanueva-Paz (10.1016/j.toxrep.2022.10.006_bib13) 2021; 10 Wang (10.1016/j.toxrep.2022.10.006_bib42) 2010; 5 10.1016/j.toxrep.2022.10.006_bib26 Green (10.1016/j.toxrep.2022.10.006_bib52) 2015; 7 Aguila (10.1016/j.toxrep.2022.10.006_bib49) 2009 Clark (10.1016/j.toxrep.2022.10.006_bib6) 2002; 122 Dludla (10.1016/j.toxrep.2022.10.006_bib29) 2014; 21 Ommati (10.1016/j.toxrep.2022.10.006_bib16) 2021; 5 Hochhauser (10.1016/j.toxrep.2022.10.006_bib48) 2008; 13 Mosmann (10.1016/j.toxrep.2022.10.006_bib33) 1983; 65 Ahmadi (10.1016/j.toxrep.2022.10.006_bib58) 2021; 349 Holder (10.1016/j.toxrep.2022.10.006_bib43) 2012; 25 10.1016/j.toxrep.2022.10.006_bib34 Navarro (10.1016/j.toxrep.2022.10.006_bib3) 2006; 354 10.1016/j.toxrep.2022.10.006_bib37 10.1016/j.toxrep.2022.10.006_bib36 Achliya (10.1016/j.toxrep.2022.10.006_bib45) 2004; 90 El-Sayed (10.1016/j.toxrep.2022.10.006_bib2) 2016; 0 Nuran Ercal (10.1016/j.toxrep.2022.10.006_bib11) 2001; 1 Erlwanger (10.1016/j.toxrep.2022.10.006_bib23) 2017; 5 Engels (10.1016/j.toxrep.2022.10.006_bib30) 2013; 1 Mancini (10.1016/j.toxrep.2022.10.006_bib53) 1998; 140 Brunt (10.1016/j.toxrep.2022.10.006_bib40) 1999; 94 Dorai (10.1016/j.toxrep.2022.10.006_bib54) 2004; 215 Leise (10.1016/j.toxrep.2022.10.006_bib4) 2014; 89 Björnsson (10.1016/j.toxrep.2022.10.006_bib5) 2015; 89 Chan (10.1016/j.toxrep.2022.10.006_bib9) 2009 10.1016/j.toxrep.2022.10.006_bib47 Yao (10.1016/j.toxrep.2022.10.006_bib51) 2016; 22 Al-Yahya (10.1016/j.toxrep.2022.10.006_bib46) 2013; 2013 |
| References_xml | – volume: 6 start-page: 363 year: 2016 ident: bib7 article-title: Drug-induced liver toxicity and prevention by herbal antioxidants: an overview publication-title: Front Physiol. – volume: 34 start-page: 172 year: 2014 end-page: 193 ident: bib20 article-title: Hepatotoxicity induced by herbal and dietary supplements publication-title: Semin Liver Dis. – volume: 5 year: 2010 ident: bib42 article-title: Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols publication-title: PLoS One – volume: 0 year: 2016 ident: bib2 article-title: Possible effects of natural antioxidants on experimentally induced hepatotoxicity in rats publication-title: CU Theses – reference: Astrid von Gadow,† , Elizabeth Joubert,*,‡ and & Hansmann‡, C.F. Comparison of the Antioxidant Activity of Aspalathin with That of Other Plant Phenols of Rooibos Tea (Aspalathus linearis), α-Tocopherol, BHT, and BHA. (1997) doi:10.1021/JF960281N. – reference: World Health Organization (WHO). WHO Global Report on Traditional and Alternate Medicine. (2019). – reference: Mechanisms of NF-κB p65 and strategies for therapeutic manipulat | JIR. – volume: 28 start-page: 690 year: 2008 end-page: 701 ident: bib50 article-title: Aspalathin, a flavonoid in Aspalathus linearis (rooibos), is absorbed by pig intestine as a C-glycoside publication-title: Nutr. Res. – reference: Lauren Standley, † et al. Influence of Processing Stages on Antimutagenic and Antioxidant Potentials of Rooibos Tea. (2000) doi: – volume: 25 start-page: 79 year: 2006 end-page: 99 ident: bib28 article-title: Beneficial effects of green tea—a review publication-title: J. Am. Coll. Nutr. – volume: 354 start-page: 731 year: 2006 end-page: 739 ident: bib3 article-title: Drug-related hepatotoxicity publication-title: N. Engl. J. Med. – volume: 20 start-page: 22674 year: 2015 end-page: 22690 ident: bib35 article-title: Short-Term and Sub-Chronic Dietary Exposure to Aspalathin-Enriched Green Rooibos (Aspalathus linearis) Extract Affects Rat Liver Function and Antioxidant Status publication-title: Molecules – reference: NF-κB in oxidative stress | Elsevier Enhanced Reader. – start-page: 1 year: 2009 end-page: 44 ident: bib49 article-title: Hepatic insulin resistance and nonalcoholic fatty liver disease publication-title: Insul. Resist.: Symptoms, Causes Treat. – volume: 94 start-page: 2467 year: 1999 end-page: 2474 ident: bib40 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am. J. Gastroenterol. – reference: Vitamin K.: A vital micronutrient with the cardioprotective potential against diabetes-associated complications | Elsevier Enhanced Reader. – volume: 121 start-page: 646 year: 2019 end-page: 656 ident: bib39 article-title: A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model publication-title: Acta Histochem – volume: 7 year: 2015 ident: bib52 article-title: Cell death signaling publication-title: Cold Spring Harb. Perspect. Biol. – volume: 21 year: 2014 ident: bib29 article-title: The cardioprotective effect of an aqueous extract of fermented rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats publication-title: Phytomedicine – volume: vol. 66 start-page: 427 year: 2010 end-page: 428 ident: bib31 article-title: Possible hepatotoxic effect of rooibos tea: A case report publication-title: Eur. J. Clin. Pharmacol. – volume: 90 start-page: 229 year: 2004 end-page: 232 ident: bib45 article-title: Evaluation of hepatoprotective effect of Amalkadi Ghrita against carbon tetrachloride-induced hepatic damage in rats publication-title: J. Ethnopharmacol. – volume: 22 start-page: 659 year: 2007 end-page: 661 ident: bib38 article-title: Dose translation from animal to human studies revisited publication-title: FASEB J. – volume: 5 start-page: 1 year: 2017 end-page: 6 ident: bib23 article-title: Aspalathin a unique phytochemical from the South African rooibos plant (Aspalathus linearis): a mini Review publication-title: J. Afr. Ass. Physiol. Sci. J. Afr. Assoc. Physiol. Sci. Off. Publ. Afr. Assoc. Physiol. Sci. – volume: 13 start-page: 77 year: 2008 end-page: 86 ident: bib48 article-title: Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model publication-title: Apoptosis – year: 2017 ident: bib41 article-title: Non-alcoholic fatty liver disease: an expanded review publication-title: Vol. 9 715–732 Prepr. – volume: 2013 year: 2013 ident: bib46 article-title: Attenuation of CCl4-induced oxidative stress and hepatonephrotoxicity by saudi sidr honey in rats publication-title: Evid. Based Complement Altern. Med – volume: 66 start-page: 1154 year: 2017 end-page: 1164 ident: bib10 article-title: Drug-induced liver injury: recent advances in diagnosis and risk assessment publication-title: Gut – volume: 3 start-page: 198 year: 2006 end-page: 211 ident: bib8 article-title: Methods to evaluate biliary excretion of drugs in humans: an updated review publication-title: Mol. Pharm. – volume: 22 start-page: 6890 year: 2016 end-page: 6905 ident: bib51 article-title: Herbal medicines and nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. – volume: 1 start-page: 58 year: 2013 end-page: 60 ident: bib30 article-title: Tea not tincture: hepatotoxicity associated with Rooibos herbal tea publication-title: ACG Case Rep. J. – reference: Ku, S.-K.K., Kwak, S., Kim, Y. & Bae, J.-S.S. Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) Inhibits High Glucose-Induced Inflammation In Vitro and In Vivo. – volume: 122 start-page: 1649 year: 2002 end-page: 1657 ident: bib6 article-title: Nonalcoholic fatty liver disease publication-title: Gastroenterology – start-page: 277 year: 2010 end-page: 294 ident: bib27 article-title: Rooibos and Honeybush: recent advances in chemistry publication-title: Biol. Act. Pharmacogn. – start-page: 341 year: 2009 end-page: 366 ident: bib9 article-title: Interaction of Natural Products with Medication and Nutrients publication-title: Handbook of Drug-Nutrient Interactions – volume: 10 year: 2021 ident: bib13 article-title: Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice publication-title: Antioxidants – volume: 140 start-page: 1485 year: 1998 end-page: 1495 ident: bib53 article-title: The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling publication-title: J. Cell Biol. – volume: 25 start-page: 1885 year: 2012 ident: bib43 article-title: Particle-induced artifacts in the MTT and LDH viability assays publication-title: Chem. Res Toxicol. – volume: 29 start-page: 337 year: 2009 end-page: 347 ident: bib1 article-title: Epidemiology of idiosyncratic drug-induced liver injury publication-title: Semin Liver Dis. – reference: Hinton, D. M. US FDA "Redbook II" Immunotoxicity Testing Guidelines and Research in Immunotoxicity Evaluations of Food Chemicals and New Food Proteins. – volume: 129 start-page: 262 year: 2018 end-page: 273 ident: bib17 article-title: Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease publication-title: Pharm. Res – volume: 44 start-page: 88 year: 2012 end-page: 106 ident: bib12 article-title: Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity publication-title: Drug Metab. Rev. – volume: vol. 21 start-page: 1 year: 2007 end-page: 16 ident: bib22 article-title: A review of the bioactivity of South African herbal teas: Rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) publication-title: Phytother. Res. – volume: 16 start-page: 437 year: 2009 end-page: 443 ident: bib24 article-title: Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice publication-title: Phytomedicine – reference: Redbook 2000: IV.B.1. General Guidelines for Designing and Conducting Toxicity Studies | FDA. – volume: 89 start-page: 327 year: 2015 end-page: 334 ident: bib5 article-title: Drug-induced liver injury: an overview over the most critical compounds publication-title: Arch. Toxicol. – reference: , 445–455. – volume: 30 start-page: 1076 year: 2001 end-page: 1081 ident: bib14 article-title: [Oxidative stress and human disease. Current knowledge and perspectives for prevention] publication-title: Presse Med. – volume: 349 start-page: 12 year: 2021 end-page: 29 ident: bib58 article-title: The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity publication-title: Toxicol. Lett. – volume: 51 start-page: 8113 year: 2003 end-page: 8119 ident: bib25 article-title: Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), green and black (Camellia Sinensis) teas in rats publication-title: J. Agric. Food Chem. – reference: . – volume: 130 start-page: 95 year: 1998 end-page: 105 ident: bib44 article-title: Evaluation of sex difference in tissue repair following acute carbon tetrachloride toxicity in male and female Sprague–Dawley rats publication-title: Toxicology – start-page: 479 year: 2013 end-page: 555 ident: bib55 article-title: Tannins and related compounds from medicinal plants of Africa publication-title: Med. Plant Res. Afr. – volume: 5 start-page: 181 year: 2021 end-page: 193 ident: bib16 article-title: Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function publication-title: Liver Res – volume: 1 start-page: 529 year: 2001 end-page: 539 ident: bib11 article-title: & Nukhet Aykin-Burns, B. S. P. Toxic Metals and Oxidative Stress Part I: Mechanisms Involved in Me-tal induced Oxidative Damage publication-title: Curr. Top. Med Chem. – volume: 21 year: 2016 ident: bib32 article-title: Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(??-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs publication-title: Molecules – volume: 65 start-page: 55 year: 1983 end-page: 63 ident: bib33 article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays publication-title: J. Immunol. Methods – volume: 215 start-page: 129 year: 2004 end-page: 140 ident: bib54 article-title: Role of chemopreventive agents in cancer therapy publication-title: Cancer Lett. – volume: 89 start-page: 95 year: 2014 end-page: 106 ident: bib4 article-title: Drug-induced liver injury publication-title: Mayo Clin. Proc. – volume: 23 start-page: 2764 year: 2022 ident: bib18 article-title: Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates publication-title: Int. J. Mol. Sci. – volume: 224 start-page: 193 year: 2005 end-page: 202 ident: bib56 article-title: Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique South African herbal teas publication-title: Cancer Lett. – volume: 25 start-page: 1885 year: 2012 ident: 10.1016/j.toxrep.2022.10.006_bib43 article-title: Particle-induced artifacts in the MTT and LDH viability assays publication-title: Chem. Res Toxicol. doi: 10.1021/tx3001708 – volume: 30 start-page: 1076 year: 2001 ident: 10.1016/j.toxrep.2022.10.006_bib14 article-title: [Oxidative stress and human disease. Current knowledge and perspectives for prevention] publication-title: Presse Med. – volume: 1 start-page: 529 year: 2001 ident: 10.1016/j.toxrep.2022.10.006_bib11 article-title: & Nukhet Aykin-Burns, B. S. P. Toxic Metals and Oxidative Stress Part I: Mechanisms Involved in Me-tal induced Oxidative Damage publication-title: Curr. Top. Med Chem. doi: 10.2174/1568026013394831 – volume: 23 start-page: 2764 year: 2022 ident: 10.1016/j.toxrep.2022.10.006_bib18 article-title: Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23052764 – volume: 94 start-page: 2467 year: 1999 ident: 10.1016/j.toxrep.2022.10.006_bib40 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.1999.01377.x – year: 2017 ident: 10.1016/j.toxrep.2022.10.006_bib41 article-title: Non-alcoholic fatty liver disease: an expanded review publication-title: World J. Hepatol. Vol. 9 715–732 Prepr. doi: 10.4254/wjh.v9.i16.715 – volume: 129 start-page: 262 year: 2018 ident: 10.1016/j.toxrep.2022.10.006_bib17 article-title: Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease publication-title: Pharm. Res doi: 10.1016/j.phrs.2017.11.030 – volume: 5 year: 2010 ident: 10.1016/j.toxrep.2022.10.006_bib42 article-title: Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols publication-title: PLoS One – ident: 10.1016/j.toxrep.2022.10.006_bib36 – volume: 140 start-page: 1485 year: 1998 ident: 10.1016/j.toxrep.2022.10.006_bib53 article-title: The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling publication-title: J. Cell Biol. doi: 10.1083/jcb.140.6.1485 – volume: 28 start-page: 690 year: 2008 ident: 10.1016/j.toxrep.2022.10.006_bib50 article-title: Aspalathin, a flavonoid in Aspalathus linearis (rooibos), is absorbed by pig intestine as a C-glycoside publication-title: Nutr. Res. doi: 10.1016/j.nutres.2008.08.002 – volume: 66 start-page: 1154 year: 2017 ident: 10.1016/j.toxrep.2022.10.006_bib10 article-title: Drug-induced liver injury: recent advances in diagnosis and risk assessment publication-title: Gut doi: 10.1136/gutjnl-2016-313369 – volume: 44 start-page: 88 year: 2012 ident: 10.1016/j.toxrep.2022.10.006_bib12 article-title: Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity publication-title: Drug Metab. Rev. doi: 10.3109/03602532.2011.602688 – start-page: 1 year: 2009 ident: 10.1016/j.toxrep.2022.10.006_bib49 article-title: Hepatic insulin resistance and nonalcoholic fatty liver disease publication-title: Insul. Resist.: Symptoms, Causes Treat. – volume: 29 start-page: 337 year: 2009 ident: 10.1016/j.toxrep.2022.10.006_bib1 article-title: Epidemiology of idiosyncratic drug-induced liver injury publication-title: Semin Liver Dis. doi: 10.1055/s-0029-1240002 – volume: vol. 66 start-page: 427 year: 2010 ident: 10.1016/j.toxrep.2022.10.006_bib31 article-title: Possible hepatotoxic effect of rooibos tea: A case report publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/s00228-009-0776-7 – volume: 51 start-page: 8113 year: 2003 ident: 10.1016/j.toxrep.2022.10.006_bib25 article-title: Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), green and black (Camellia Sinensis) teas in rats publication-title: J. Agric. Food Chem. doi: 10.1021/jf0344643 – volume: 1 start-page: 58 year: 2013 ident: 10.1016/j.toxrep.2022.10.006_bib30 article-title: Tea not tincture: hepatotoxicity associated with Rooibos herbal tea publication-title: ACG Case Rep. J. doi: 10.14309/crj.2013.20 – volume: 89 start-page: 327 year: 2015 ident: 10.1016/j.toxrep.2022.10.006_bib5 article-title: Drug-induced liver injury: an overview over the most critical compounds publication-title: Arch. Toxicol. doi: 10.1007/s00204-015-1456-2 – volume: 22 start-page: 659 year: 2007 ident: 10.1016/j.toxrep.2022.10.006_bib38 article-title: Dose translation from animal to human studies revisited publication-title: FASEB J. doi: 10.1096/fj.07-9574LSF – volume: 130 start-page: 95 year: 1998 ident: 10.1016/j.toxrep.2022.10.006_bib44 article-title: Evaluation of sex difference in tissue repair following acute carbon tetrachloride toxicity in male and female Sprague–Dawley rats publication-title: Toxicology doi: 10.1016/S0300-483X(98)00095-X – volume: 121 start-page: 646 year: 2019 ident: 10.1016/j.toxrep.2022.10.006_bib39 article-title: A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model publication-title: Acta Histochem doi: 10.1016/j.acthis.2019.05.008 – start-page: 479 year: 2013 ident: 10.1016/j.toxrep.2022.10.006_bib55 article-title: Tannins and related compounds from medicinal plants of Africa publication-title: Med. Plant Res. Afr. doi: 10.1016/B978-0-12-405927-6.00013-8 – volume: 0 year: 2016 ident: 10.1016/j.toxrep.2022.10.006_bib2 article-title: Possible effects of natural antioxidants on experimentally induced hepatotoxicity in rats publication-title: CU Theses – volume: 65 start-page: 55 year: 1983 ident: 10.1016/j.toxrep.2022.10.006_bib33 article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays publication-title: J. Immunol. Methods doi: 10.1016/0022-1759(83)90303-4 – ident: 10.1016/j.toxrep.2022.10.006_bib21 doi: 10.1021/jf960281n – ident: 10.1016/j.toxrep.2022.10.006_bib37 – start-page: 277 year: 2010 ident: 10.1016/j.toxrep.2022.10.006_bib27 article-title: Rooibos and Honeybush: recent advances in chemistry publication-title: Biol. Act. Pharmacogn. – ident: 10.1016/j.toxrep.2022.10.006_bib47 doi: 10.1007/s10753-014-0049-1 – volume: 122 start-page: 1649 year: 2002 ident: 10.1016/j.toxrep.2022.10.006_bib6 article-title: Nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/gast.2002.33573 – volume: 6 start-page: 363 year: 2016 ident: 10.1016/j.toxrep.2022.10.006_bib7 article-title: Drug-induced liver toxicity and prevention by herbal antioxidants: an overview publication-title: Front Physiol. doi: 10.3389/fphys.2015.00363 – volume: vol. 21 start-page: 1 year: 2007 ident: 10.1016/j.toxrep.2022.10.006_bib22 article-title: A review of the bioactivity of South African herbal teas: Rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) publication-title: Phytother. Res. doi: 10.1002/ptr.1992 – volume: 21 year: 2016 ident: 10.1016/j.toxrep.2022.10.006_bib32 article-title: Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(??-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs publication-title: Molecules doi: 10.3390/molecules21111515 – volume: 13 start-page: 77 year: 2008 ident: 10.1016/j.toxrep.2022.10.006_bib48 article-title: Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model publication-title: Apoptosis doi: 10.1007/s10495-007-0155-8 – volume: 224 start-page: 193 year: 2005 ident: 10.1016/j.toxrep.2022.10.006_bib56 article-title: Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique South African herbal teas publication-title: Cancer Lett. doi: 10.1016/j.canlet.2004.11.014 – ident: 10.1016/j.toxrep.2022.10.006_bib57 – start-page: 341 year: 2009 ident: 10.1016/j.toxrep.2022.10.006_bib9 article-title: Interaction of Natural Products with Medication and Nutrients – volume: 21 year: 2014 ident: 10.1016/j.toxrep.2022.10.006_bib29 article-title: The cardioprotective effect of an aqueous extract of fermented rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats publication-title: Phytomedicine doi: 10.1016/j.phymed.2013.10.029 – volume: 20 start-page: 22674 year: 2015 ident: 10.1016/j.toxrep.2022.10.006_bib35 article-title: Short-Term and Sub-Chronic Dietary Exposure to Aspalathin-Enriched Green Rooibos (Aspalathus linearis) Extract Affects Rat Liver Function and Antioxidant Status publication-title: Molecules doi: 10.3390/molecules201219868 – ident: 10.1016/j.toxrep.2022.10.006_bib15 – ident: 10.1016/j.toxrep.2022.10.006_bib34 – volume: 16 start-page: 437 year: 2009 ident: 10.1016/j.toxrep.2022.10.006_bib24 article-title: Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice publication-title: Phytomedicine doi: 10.1016/j.phymed.2008.11.009 – volume: 3 start-page: 198 year: 2006 ident: 10.1016/j.toxrep.2022.10.006_bib8 article-title: Methods to evaluate biliary excretion of drugs in humans: an updated review publication-title: Mol. Pharm. doi: 10.1021/mp060011k – volume: 10 issue: 390 year: 2021 ident: 10.1016/j.toxrep.2022.10.006_bib13 article-title: Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice publication-title: Antioxidants – ident: 10.1016/j.toxrep.2022.10.006_bib19 – volume: 25 start-page: 79 year: 2006 ident: 10.1016/j.toxrep.2022.10.006_bib28 article-title: Beneficial effects of green tea—a review publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2006.10719518 – volume: 7 year: 2015 ident: 10.1016/j.toxrep.2022.10.006_bib52 article-title: Cell death signaling publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a006080 – volume: 5 start-page: 181 year: 2021 ident: 10.1016/j.toxrep.2022.10.006_bib16 article-title: Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function publication-title: Liver Res doi: 10.1016/j.livres.2020.10.003 – volume: 90 start-page: 229 year: 2004 ident: 10.1016/j.toxrep.2022.10.006_bib45 article-title: Evaluation of hepatoprotective effect of Amalkadi Ghrita against carbon tetrachloride-induced hepatic damage in rats publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2003.09.037 – volume: 349 start-page: 12 year: 2021 ident: 10.1016/j.toxrep.2022.10.006_bib58 article-title: The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2021.05.012 – volume: 5 start-page: 1 year: 2017 ident: 10.1016/j.toxrep.2022.10.006_bib23 article-title: Aspalathin a unique phytochemical from the South African rooibos plant (Aspalathus linearis): a mini Review publication-title: J. Afr. Ass. Physiol. Sci. J. Afr. Assoc. Physiol. Sci. Off. Publ. Afr. Assoc. Physiol. Sci. – volume: 22 start-page: 6890 year: 2016 ident: 10.1016/j.toxrep.2022.10.006_bib51 article-title: Herbal medicines and nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v22.i30.6890 – volume: 215 start-page: 129 year: 2004 ident: 10.1016/j.toxrep.2022.10.006_bib54 article-title: Role of chemopreventive agents in cancer therapy publication-title: Cancer Lett. doi: 10.1016/j.canlet.2004.07.013 – volume: 354 start-page: 731 year: 2006 ident: 10.1016/j.toxrep.2022.10.006_bib3 article-title: Drug-related hepatotoxicity publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra052270 – volume: 89 start-page: 95 year: 2014 ident: 10.1016/j.toxrep.2022.10.006_bib4 article-title: Drug-induced liver injury publication-title: Mayo Clin. Proc. doi: 10.1016/j.mayocp.2013.09.016 – ident: 10.1016/j.toxrep.2022.10.006_bib26 doi: 10.1021/jf000802d – volume: 2013 year: 2013 ident: 10.1016/j.toxrep.2022.10.006_bib46 article-title: Attenuation of CCl4-induced oxidative stress and hepatonephrotoxicity by saudi sidr honey in rats publication-title: Evid. Based Complement Altern. Med doi: 10.1155/2013/569037 – volume: 34 start-page: 172 year: 2014 ident: 10.1016/j.toxrep.2022.10.006_bib20 article-title: Hepatotoxicity induced by herbal and dietary supplements publication-title: Semin Liver Dis. doi: 10.1055/s-0034-1375958 |
| SSID | ssj0001256054 |
| Score | 2.2239773 |
| Snippet | The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as Rooibos showed... ga1 • Afriplex GRT sub-chronic administration to Sprague Dawley does not impact the liver histology. • High dosage of Afriplex GRT increases the AST levels... Background: The focus on traditional and complementary medicine for supplementation and treatment of diseases is high. Aspalathus linearis commonly known as... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1920 |
| SubjectTerms | alanine transaminase alternative medicine Aspalathin-rich Aspalathus linearis aspartate transaminase blood chemistry blood serum carbon tetrachloride cell viability dose response Hepatotoxicity HepG2/C3A histology inflammation liver Regular Rooibos Sprague Dawley toxicology Western blotting |
| Title | In vitro and in vivo hepatotoxicity study of Afriplex™ GRT through an inflammatory response |
| URI | https://dx.doi.org/10.1016/j.toxrep.2022.10.006 https://www.ncbi.nlm.nih.gov/pubmed/36518449 https://www.proquest.com/docview/2754856720 https://www.proquest.com/docview/2834250805 https://pubmed.ncbi.nlm.nih.gov/PMC9742939 https://doaj.org/article/66529278072a4849827df390f96315a7 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2214-7500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001256054 issn: 2214-7500 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2214-7500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001256054 issn: 2214-7500 databaseCode: M~E dateStart: 20140101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELag4oCEEG-WR2UkrobE7xwBtYAEFUJF2guKHMdWU5WkStNVTz31l_DT-CWM7WS1AYm9cFntZu3deGaS-caZ-Qahl3klpJeiIBmjjPDCCFJUuSQ1rzOma6lHyvxP6uBAL5fFl41WXyEnLNEDJ8G9llLQgiqdKWq45oWmqvYQqHuwnFyYWEcOqGcjmEq7K-DJYws0SnNOwC1mU91cTO4auoveBbpKSl-l5K6ZX4r0_TP39Df8_DOLcsMt7d9Bt0c8id-kddxF11x7D91Km3E41RjdR98_tnjVDH2HTVvjJnxYdfgIPNHQwTk2FqA4jkSzuPM4tA46PXEXv65-4vdfD_HYygfmwlQPFvQjPpnHfUqvdQ_Qt_29w3cfyNhXgViulCSGm1BgClDKggLhrQtZ08KIkE9aeS-4NI6CnGtjjfM2FzVjFnRqqPHOUvYQ7bRd6x4jnHmAQ1kNN3xqua6MYRAu-sprHYobOF0gNkm1tCPpeOh9cVJO2WXHZdJFGXQRjoIuFoisZ50m0o0t498Gha3HBsrseAAMqRwNqdxmSAukJnWXI_pIqAJ-qtny9y8m6yjh4gxPXEzruvOzkioICIVUNPvHGA1yApiciQV6lCxqvRAmBUTgvIBzm9nabKXzb9rmKJKEQ5wISK548j9E8xTdDMtNO0_P0M7Qn7vn6IZdDc1Zv4uuq6XejdcfvH6-3PsNj5MzfA |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+and+in+vivo+hepatotoxicity+study+of+Afriplex%E2%84%A2+GRT+through+an+inflammatory+response&rft.jtitle=Toxicology+reports&rft.au=Gabuza%2C+Kwazikwakhe+B.&rft.au=Buthelezi%2C+Ntandoyenkosi&rft.au=Kappo%2C+Abidemi+Paul&rft.au=Mabuda%2C+Thendo+I.&rft.date=2022-01-01&rft.pub=Elsevier&rft.eissn=2214-7500&rft.volume=9&rft.spage=1920&rft.epage=1928&rft_id=info:doi/10.1016%2Fj.toxrep.2022.10.006&rft.externalDocID=PMC9742939 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-7500&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-7500&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-7500&client=summon |